
Valerie Rodriguez-garcia
Examiner (ID: 10379, Phone: (571)270-5865 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1622, 1626, 1759 |
| Total Applications | 1115 |
| Issued Applications | 735 |
| Pending Applications | 95 |
| Abandoned Applications | 322 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13479029
[patent_doc_number] => 20180291057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => OXYSTEROLS FOR USE IN THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY VIRUSES
[patent_app_type] => utility
[patent_app_number] => 15/877831
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877831 | OXYSTEROLS FOR USE IN THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY VIRUSES | Jan 22, 2018 | Abandoned |
Array
(
[id] => 13314127
[patent_doc_number] => 20180208600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/872571
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15872571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/872571 | BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF | Jan 15, 2018 | Abandoned |
Array
(
[id] => 14003175
[patent_doc_number] => 10220015
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Fumigillol compounds and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 15/869368
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 10236
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15869368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/869368 | Fumigillol compounds and methods of making and using same | Jan 11, 2018 | Issued |
Array
(
[id] => 17421204
[patent_doc_number] => 11254645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Method for preparing tolimidone on large scale
[patent_app_type] => utility
[patent_app_number] => 16/960796
[patent_app_country] => US
[patent_app_date] => 2018-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 4003
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960796 | Method for preparing tolimidone on large scale | Jan 10, 2018 | Issued |
Array
(
[id] => 15666309
[patent_doc_number] => 10597372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Simplified structural mimetics of AIPS as quorum sensing inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/850300
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 21645
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15850300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/850300 | Simplified structural mimetics of AIPS as quorum sensing inhibitors | Dec 20, 2017 | Issued |
Array
(
[id] => 15483175
[patent_doc_number] => 10556920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Phosphorus-containing heterocycles and a method for making and using
[patent_app_type] => utility
[patent_app_number] => 15/850388
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9710
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15850388
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/850388 | Phosphorus-containing heterocycles and a method for making and using | Dec 20, 2017 | Issued |
Array
(
[id] => 15491553
[patent_doc_number] => 20200045965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => METHOD FOR THE CONTROL OF PLANT BACTERIAL DISEASES USING CARBOXAMIDE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/469735
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469735 | METHOD FOR THE CONTROL OF PLANT BACTERIAL DISEASES USING CARBOXAMIDE DERIVATIVES | Dec 13, 2017 | Abandoned |
Array
(
[id] => 13621821
[patent_doc_number] => 20180362462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => ANTIMICROBIAL COMPOUNDS AND NANOSTRUCTURES
[patent_app_type] => utility
[patent_app_number] => 15/838751
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15838751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/838751 | Antimicrobial compounds and nanostructures | Dec 11, 2017 | Issued |
Array
(
[id] => 16688207
[patent_doc_number] => 20210070683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/464606
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464606
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464606 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | Nov 29, 2017 | Abandoned |
Array
(
[id] => 17029685
[patent_doc_number] => 11091490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/464860
[patent_app_country] => US
[patent_app_date] => 2017-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 2
[patent_no_of_words] => 18853
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464860 | 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors | Nov 28, 2017 | Issued |
Array
(
[id] => 17119638
[patent_doc_number] => 11130760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => Polymorphic form of sepiapterin
[patent_app_type] => utility
[patent_app_number] => 16/464916
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 20893
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464916 | Polymorphic form of sepiapterin | Nov 27, 2017 | Issued |
Array
(
[id] => 16230464
[patent_doc_number] => 10738002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Halogenated benzotropolones as ATG4B inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/463544
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16369
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463544 | Halogenated benzotropolones as ATG4B inhibitors | Nov 23, 2017 | Issued |
Array
(
[id] => 12813181
[patent_doc_number] => 20180162897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => TRICYCLIC NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 15/821222
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821222 | TRICYCLIC NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM | Nov 21, 2017 | Abandoned |
Array
(
[id] => 16533246
[patent_doc_number] => 10875829
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-12-29
[patent_title] => Azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
[patent_app_type] => utility
[patent_app_number] => 16/461086
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27447
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461086 | Azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission | Nov 16, 2017 | Issued |
Array
(
[id] => 17648452
[patent_doc_number] => 11351151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Compound having anticancer activity and preparation method and application
[patent_app_type] => utility
[patent_app_number] => 16/461828
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 13580
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461828
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461828 | Compound having anticancer activity and preparation method and application | Nov 16, 2017 | Issued |
Array
(
[id] => 16842846
[patent_doc_number] => 11014920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Factor XIIa inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/461825
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11318
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461825 | Factor XIIa inhibitors | Nov 12, 2017 | Issued |
Array
(
[id] => 12205747
[patent_doc_number] => 20180050973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'VINYL-GROUP-CONTAINING FLUORENE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/800902
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15048
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15800902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/800902 | VINYL-GROUP-CONTAINING FLUORENE COMPOUND | Oct 31, 2017 | Abandoned |
Array
(
[id] => 16072141
[patent_doc_number] => 20200190057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => CRYSTALLINE FORMS OF 4-(2-((1R,2R)-2-HYDROXYCYCLOHEXYLAMINO)BENZOTHIAZOL-6-YLOXY)-N-METHYLPICOLINAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/341124
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341124
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341124 | Crystalline forms of 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-N-methylpicolinamide | Oct 12, 2017 | Issued |
Array
(
[id] => 14820849
[patent_doc_number] => 10407416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Kappa opioid agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/719376
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48502
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15719376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/719376 | Kappa opioid agonists and uses thereof | Sep 27, 2017 | Issued |
Array
(
[id] => 14715377
[patent_doc_number] => 20190248752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => HETEROCYCLIC FXR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/343748
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343748 | Heterocyclic containing cyclopropyl FXR modulators | Sep 26, 2017 | Issued |